If nausea, constipation, or other issues show up, we help you troubleshoot quickly and can slow titration or adjust the plan
Building on these findings, clinical trials are now investigating these therapeutic applications more systematically, including studies examining incretin agonists for both alcohol consumption and alcohol-related disorders (ClinicalTrials.gov identifiers: NCT06546384, NCT06409130, NCT07046819, NCT05891587, NCT05895643, NCT06015893, NCT05892432, NCT06939088, NCT06727331, and NCT06994338)
Weekly GLP-1 injections: Zepbound both vial and prefilled pen (tirzepatide)
Retatrutide is an investigational therapy for people with metabolic health issues, primarily those with obesity or metabolic dysfunction
A simple note in your phone each time you have a drink provides data you can review with your healthcare provider